Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000827·ATOSSA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Atossa Therapeutics Inc
Common Stock · CUSIP: 04962H506
Event date: 2025-06-30
- Filing-level shares
- 5,833,127
- Percent of class
- 4.51%
- The Vanguard Group
Shares: 5,833,127 · Class: 4.51%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000827
- Form type
- SCHEDULE 13G/A
- Filer
- ATOSSA THERAPEUTICS, INC.
- CIK
- CIK 1488039
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership